Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $110.1 million.

  • Veracyte's Total Liabilities rose 1125.59% to $110.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $110.1 million, marking a year-over-year increase of 1125.59%. This contributed to the annual value of $124.1 million for FY2024, which is 7522.88% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Total Liabilities is $110.1 million, which was up 1125.59% from $123.0 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Total Liabilities ranged from a high of $124.1 million in Q4 2024 and a low of $50.9 million during Q1 2021
  • Its 5-year average for Total Liabilities is $87.4 million, with a median of $81.2 million in 2022.
  • Its Total Liabilities has fluctuated over the past 5 years, first skyrocketed by 15412.87% in 2021, then crashed by 1418.45% in 2023.
  • Quarter analysis of 5 years shows Veracyte's Total Liabilities stood at $91.3 million in 2021, then decreased by 11.05% to $81.2 million in 2022, then fell by 12.83% to $70.8 million in 2023, then skyrocketed by 75.23% to $124.1 million in 2024, then decreased by 11.24% to $110.1 million in 2025.
  • Its last three reported values are $110.1 million in Q3 2025, $123.0 million for Q2 2025, and $120.5 million during Q1 2025.